FBFrederic Bretagnol

Frederic Bretagnol

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Frederic Bretagnol has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Colorectal surgery for functional bowel disorders

    by F. Bretagnol, E. Hain, D. Moszkowicz, D. Giovinazzo

  • Bowel preparation with oral antibiotics for elective colorectal surgery: back to the future?

    by Frederic Bretagnol, Arthur Wijsmuller, Son Nguyen, Dan Nguyen, Joël Leroy

    There is controversy regarding the use of preoperative mechanical bowel preparation (MBP) before elective colorectal surgery. Factual data have led many European learned societies not to recommend MBP whereas its use remains widespread among US surgeons. This review was assessed to clarify the role of preoperative MBP and oral antibiotics. We searched PubMed, Embase, and the Cochrane Library for relevant literature. Search terms included preoperative bowel preparation, oral antibiotics, colorectal surgery and postoperative morbidity. MBP combined with oral antibiotics before elective colorectal surgery remains a present subject of debate within the surgical community. Over a century ago, MBP was considered, dogmatically, as a standard surgical practice. But, the gradual spread of minimally invasive surgery as laparoscopy in colorectal procedures added to enhanced recovery after surgery (ERAS) program promoted its abandonment. Therefore, several large retrospective studies recently questioned the abandonment of MBP suggesting that its omission was deleterious in terms of surgical sites infection (SSI) and anastomotic leakage, especially when MBP was combined with oral antibiotics.


  • Pure Transanal Laparoscopic TME without Abdominal Laparoscopy

    by Joel Leroy, Usmaan Hameed, Ntourakis Dimitrios, Frédéric Bretagnol


  • Laparoscopic resection for T4 colon cancer: perioperative and long-term outcomes

    by Frederic Bretagnol, Joel Leroy

    Laparoscopic resection has been considered a contraindication for T4 colorectal cancer. It is argued that it is a challenging and demanding procedure with high conversion rate, inadequate oncologic clearance and surgical outcomes. There are only a few data on short- and long-term operative results. This review aimed at assessing feasibility and operative and oncologic results of laparoscopic resection for T4 colorectal cancer.


  • Robotic-assisted Transanal Total Mesorectal Excision

    by Cristiano G. S. Huscher, Frederic Bretagnol, Cecilia Ponzano


  • Laparoscopic Colorectal Cancer Resection in High‐Volume Surgical Centers: Long‐Term Outcomes from the LAPCOLON Group Trial

    by Cristiano G. S. Huscher, Frederic Bretagnol, Francesco Corcione

    Background: Strong evidence has confirmed the benefit of laparoscopy in colorectal cancer resection but remains a challenging procedure. It is not clear that such promising results in selected patients translate into a favorable risk–benefit balance in real practice. We conducted a multicenter national observational registry to assess operative and oncologic long‐term outcomes following laparoscopic colorectal cancer resection.Methods: All patients with laparoscopic colorectal cancer resection between 2001 and 2004 were included. Data were extracted from the prospective Italian national database of 10 high‐volume centers (≥40 colorectal cancer laparoscopic resections per year). Surgical technique and follow‐up were standardized. Survivals were analyzed by Kaplan–Meier method.Results: We reported 1832 patients with colon (58.5 %) and rectal cancer (41.5 %). TNM stage was 0–I–II in 1044 patients (57 %) and III–IV in 788 patients (43 %). Surgery included a totally laparoscopic procedure in 1820 patients (99.3 %). Conversion was 10.5 %. Postoperative morbidity and 30‐day mortality rates were 17 and 1.2 %, respectively. Clinical anastomotic leakage rate was 8.3 % (n = 152). R0 resection was 95 %. With a median follow‐up of 54.2 months, cancer recurrence rate was 13.3 %. At 5 years, cancer‐free survival was 86.7 %. Upon multivariate analysis, age (P = 0.001) and TNM stage (P < 0.001) were associated with cancer‐free survival. Predictive factors of cancer recurrence were gender (P = 0.029) and TNM stage (P < 0.001).Conclusions: In high‐volume centers and non‐selective patients, laparoscopic colorectal resection for cancer achieves good operative results with satisfactory long‐term oncologic results. Even in the laparoscopy era, age, gender, and TNM stage remain the most powerful predictor of oncologic outcomes.


  • Open Access

    Determinants of outcome following laparoscopic peritoneal lavage for perforated diverticulitis

    by F Radé, F Bretagnol, M Auguste, C Di Guisto, N Huten, L de Calan

    Background: Laparoscopic peritoneal lavage has been proposed for generalized peritonitis from perforated diverticulitis to avoid a stoma. Reports of its feasibility and safety are promising. This study aimed to establish determinants of failure to enable improved selection of patients for this approach. Methods: The study included all patients with perforated sigmoid diverticulitis who underwent emergency laparoscopic peritoneal lavage from January 2000 to December 2013. Factors predicting failure of laparoscopic treatment were analysed from data collected retrospectively. Results: For patients undergoing emergency sigmoid resection (72 of 361), mortality and morbidity rates were 13 and 35 per cent respectively. In all, 71 patients had laparoscopic lavage, with mortality and morbidity rates of 6 and 28 per cent respectively. Reintervention was necessary in 11 patients (15 per cent) for unresolved sepsis. Age 80 years or more, American Society of Anesthesiologists grade III or above, and immunosuppression were associated with reintervention. Conclusion: Elderly patients and those with immunosuppression or severe systemic co-morbidity are at risk of reintervention after laparoscopic lavage.


    • 1 December 2003
      • Vol. 27  (12) , 1163-5

    [Recurrent glucagonoma 20 years after surgical resection].

    by Karine Pautrat, Frédéric Bretagnol, Anne De Muret, Loïk De Calan

    Glucagonoma is a rare islet alpha-cell pancreatic tumor. Patients usually present with necrolytic migratory erythema, diabetes mellitus, thromboembolism, and weight loss. Diagnosis is based on the presence of a pancreatic tumor in association with hyperglucagonemia. Tumor characterization is made by computed tomography and/or pancreatic endoscopic ultrasonic and indium-labeled octreo-scan. Surgery is the main component of the treatment, in some cases in association with chemotherapy. We report the case of a 72-year-old patient who developed a recurrent glucagonoma, 20 years after surgical resection.

    • 1 October 2003
      • Vol. 27  (10) , 949-50

    [Inflammatory duodeno-jejunal pseudopolyp caused by foreign body].

    by Karine Pautrat, Frédéric Bretagnol, Anne De Muret, Jean-Luc Eymin, Loïk De Calan